Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Marion Peters, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address513 Parnassus Ave, Med Sci
    San Francisco CA 94143
    Phone415-502-0318

       ORNG Applications 
       Websites
       Awarded Grants
       Global Health
       Featured Videos

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Decaris ML, Emson CL, Li K, Gatmaitan M, Luo F, Cattin J, Nakamura C, Holmes WE, Angel TE, Peters MG, Turner SM, Hellerstein MK. Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. PLoS One. 2015; 10(4):e0123311.
        View in: PubMed
      2. Vijayan T, Zheng P, Nguyen C, Brown AM, Chen YW, Peters MG. Survey of asian patients with hepatitis B infection: limited knowledge of transmission and screening of family members. J Immigr Minor Health. 2015 Feb; 17(1):112-7.
        View in: PubMed
      3. Kuniholm MH, Xie X, Anastos K, Kaplan RC, Xue X, Kovacs A, Peters MG, Seaberg EC, French AL, Young MA, Augenbraun M, Martinson JA, Bush KA, Landay AL, Strickler HD. Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women. J Acquir Immune Defic Syndr. 2014 Nov 1; 67(3):295-303.
        View in: PubMed PMC4197408
      4. Campos-Varela I, Peters MG, Terrault NA. Advances in Therapy for HIV/Hepatitis C Virus-Coinfected Patients in the Liver Transplant Setting. Clin Infect Dis. 2015 Jan 1; 60(1):108-16.
        View in: PubMed
      5. Sarkar M, Shvachko VA, Ready JB, Pauly MP, Terrault NA, Peters MG, Manos MM. Characteristics and management of patients with chronic hepatitis B in an integrated care setting. Dig Dis Sci. 2014 Sep; 59(9):2100-8.
        View in: PubMed PMC4149592
      6. Wojcik GL, Thio CL, Kao WH, Latanich R, Goedert JJ, Mehta SH, Kirk GD, Peters MG, Cox AL, Kim AY, Chung RT, Thomas DL, Duggal P. Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent. Genes Immun. 2014 Apr; 15(4):241-6.
        View in: PubMed
      7. Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG. Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. HIV Clin Trials. 2013 Nov-Dec; 14(6):274-83.
        View in: PubMed PMC4113390
      8. Guy J, Peters MG. Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol (N Y). 2013 Oct; 9(10):633-9.
        View in: PubMed PMC3992057
      9. Lai JC, Kahn JG, Tavakol M, Peters MG, Roberts JP. Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2013 Oct; 13(10):2611-8.
        View in: PubMed PMC4091990
      10. Aka PV, Kuniholm MH, Pfeiffer RM, Wang AS, Tang W, Chen S, Astemborski J, Plankey M, Villacres MC, Peters MG, Desai S, Seaberg EC, Edlin BR, Strickler HD, Thomas DL, Prokunina-Olsson L, Sharp GB, O'Brien TR. Association of the IFNL4-?G Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. J Infect Dis. 2014 Feb 1; 209(3):350-4.
        View in: PubMed PMC3883162
      11. Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, Cyster JG, Erle DJ, Rosenthal P, Cooper S, Baron JL. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest. 2013 Sep 3; 123(9):3728-39.
        View in: PubMed PMC3754256
      12. Bailony MR, Scherzer R, Huhn G, Plankey MW, Peters MG, Tien PC. Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography. J Infect Dis. 2013 Dec 1; 208(11):1776-83.
        View in: PubMed PMC3814832
      13. Price H, Dunn D, Pillay D, Bani-Sadr F, de Vries-Sluijs T, Jain MK, Kuzushita N, Mauss S, Núñez M, Nüesch R, Peters M, Reiberger T, Stephan C, Tan L, Gilson R. Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis. PLoS One. 2013; 8(7):e68152.
        View in: PubMed PMC3707972
      14. French AL, Evans CT, Agniel DM, Cohen MH, Peters M, Landay AL, Desai SN. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J Infect Dis. 2013 Aug 15; 208(4):679-89.
        View in: PubMed PMC3719907
      15. Kuniholm MH, Parrinello CM, Anastos K, Augenbraun M, Plankey M, Nowicki M, Peters M, Golub ET, Lurain N, Landay AL, Strickler HD, Kaplan RC. Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women. PLoS One. 2013; 8(4):e61973.
        View in: PubMed PMC3629158
      16. Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DL. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med. 2013 Feb 19; 158(4):235-45.
        View in: PubMed PMC3638215
      17. Sarkar M, Bacchetti P, Tien P, Mileti E, French AL, Edlin BR, Keller M, Seaberg E, Nowicki MJ, Young M, Peters MG. Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women. Dig Dis Sci. 2013 May; 58(5):1341-8.
        View in: PubMed PMC3663918
      18. Sarkar M, Bacchetti P, French AL, Tien P, Glesby MJ, Nowicki M, Plankey M, Gange S, Sharp G, Minkoff H, Peters MG. Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women. Hepatology. 2012 Nov; 56(5):1699-705.
        View in: PubMed PMC3440547
      19. McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM. Untreated HIV infection is associated with higher blood alcohol levels. J Acquir Immune Defic Syndr. 2012 Jul 1; 60(3):282-8.
        View in: PubMed PMC3723399
      20. Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS. 2012 Mar 13; 26(5):599-607.
        View in: PubMed PMC3698040
      21. Thomas DL, Bartlett JG, Peters MG, Sherman KE, Sulkowski MS, Pham PA. Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clin Infect Dis. 2012 Apr; 54(7):979-83.
        View in: PubMed PMC3404695
      22. Crystal H, Kleyman I, Anastos K, Lazar J, Cohen M, Liu C, Pearce L, Golub E, Valcour V, Ho A, Strickler H, Peters M, Kovacs A, Holman S, Kreek MJ, Manly J. Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2012 Feb 1; 59(2):149-54.
        View in: PubMed PMC3319079
      23. Mileti E, Rosenthal P, Peters MG. Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children. Clin Gastroenterol Hepatol. 2012 Apr; 10(4):417-21.e1-2.
        View in: PubMed PMC3321372
      24. Soriano V, Sherman KE, Rockstroh J, Dieterich D, Back D, Sulkowski M, Peters M. Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients. AIDS. 2011 Nov 28; 25(18):2197-208.
        View in: PubMed
      25. Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters MG. Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia. J Acquir Immune Defic Syndr. 2011 Nov 1; 58(3):e96-9.
        View in: PubMed PMC4120944
      26. Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, Peters MG, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, Carrington M. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis. 2011 Jun 15; 203(12):1807-14.
        View in: PubMed PMC3100515
      27. Coffin CS, Mulrooney-Cousins PM, Peters MG, van Marle G, Roberts JP, Michalak TI, Terrault NA. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat. 2011 Jun; 18(6):415-23.
        View in: PubMed PMC4142495
      28. Anthony DD, Umbleja T, Aberg JA, Kang M, Medvik K, Lederman MM, Peters MG, Koziel MJ, Overton ET. Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals. Vaccine. 2011 Apr 27; 29(19):3558-63.
        View in: PubMed PMC3081920
      29. Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD, Chung RT. Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C). J Acquir Immune Defic Syndr. 2010 Dec 15; 55(5):597-605.
        View in: PubMed PMC3017670
      30. Ghotb A, Noworolski SM, Madden E, Scherzer R, Qayyum A, Pannell J, Ferrell L, Peters M, Tien PC. Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):228-31.
        View in: PubMed PMC2943991
      31. Bhattacharya D, Umbleja T, Carrat F, Chung RT, Peters MG, Torriani F, Andersen J, Currier JS. Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):170-5.
        View in: PubMed PMC2943974
      32. Tu Z, Li Q, Chou HS, Hsieh CC, Meyerson H, Peters MG, Bu H, Fung JJ, Qian S, Lu L, Lin F. Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology. 2011 Apr; 216(4):528-34.
        View in: PubMed PMC3557916
      33. Overton ET, Kang M, Peters MG, Umbleja T, Alston-Smith BL, Bastow B, Demarco-Shaw D, Koziel MJ, Mong-Kryspin L, Sprenger HL, Yu JY, Aberg JA. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. Vaccine. 2010 Aug 2; 28(34):5597-604.
        View in: PubMed PMC2943846
      34. Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL. Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. J Infect Dis. 2010 May 1; 201(9):1371-80.
        View in: PubMed PMC2853721
      35. Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, Carrington M. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology. 2010 May; 51(5):1514-22.
        View in: PubMed PMC2946382
      36. Peters MG, Weinbaum C, Tan L, Baine WB, Dienstag JL, Liang TJ, So S. Recommendations for prevention, screening, and diagnosis of HBV and HCV infections. J Fam Pract. 2010 Apr; 59(4 Suppl):S29-35.
        View in: PubMed
      37. Peters MG, Perrillo RP, Jacobson IM, Ross DB, Doo EC, Murray JS, Wong JB. Entering the new era of therapy for HBV and HCV infections. J Fam Pract. 2010 Apr; 59(4 Suppl):S51-8.
        View in: PubMed
      38. Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. J Infect Dis. 2010 Mar; 201(5):712-9.
        View in: PubMed PMC2827649
      39. Peters MG. End-stage liver disease in HIV disease. Top HIV Med. 2009 Sep-Oct; 17(4):124-8.
        View in: PubMed
      40. French AL, Lin MY, Evans CT, Benning L, Glesby MJ, Young MA, Operskalski EA, Augenbraun M, Peters M. Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clin Infect Dis. 2009 Jul 1; 49(1):148-54.
        View in: PubMed PMC2743413
      41. Peters MG. Special populations with hepatitis B virus infection. Hepatology. 2009 May; 49(5 Suppl):S146-55.
        View in: PubMed
      42. Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, Cohen MH, Peters MG, Golub ET, Szczech L. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study. Am J Kidney Dis. 2009 Jul; 54(1):43-50.
        View in: PubMed PMC2997705
      43. Soriano V, Peters MG, Zeuzem S. New therapies for hepatitis C virus infection. Clin Infect Dis. 2009 Feb 1; 48(3):313-20.
        View in: PubMed
      44. Soriano V, Peters M, Rockstroh J. Fourth HIV & Hepatitis Coinfection Workshop; June 19-21, 2008; Madrid, Spain. HIV Clin Trials. 2009 Jan-Feb; 10(1):52-62.
        View in: PubMed
      45. Duong TH, Nguyen PH, Henley K, Peters M. Risk factors for hepatitis B infection in rural Vietnam. Asian Pac J Cancer Prev. 2009 Jan-Mar; 10(1):97-102.
        View in: PubMed PMC4130560
      46. Mayo MJ, Parkes J, Adams-Huet B, Combes B, Mills AS, Markin RS, Rubin R, Wheeler D, Contos M, West AB, Saldana S, Getachew Y, Butsch R, Luketic V, Peters M, Di Bisceglie A, Bass N, Lake J, Boyer T, Martinez E, Boyer J, Garcia-Tsao G, Barnes D, Rosenberg WM. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology. 2008 Nov; 48(5):1549-57.
        View in: PubMed PMC2597274
      47. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep; 48(3):819-27.
        View in: PubMed PMC4142499
      48. Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, Mauss S, Rockstroh J. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS. 2008 Jul 31; 22(12):1399-410.
        View in: PubMed
      49. Choi G, Peters MG. The challenge of diagnosing autoimmune hepatitis: less is more. Hepatology. 2008 Jul; 48(1):10-2.
        View in: PubMed
      50. Buxbaum J, Qian P, Allen PM, Peters MG. Hepatitis resulting from liver-specific expression and recognition of self-antigen. J Autoimmun. 2008 Nov; 31(3):208-15.
        View in: PubMed PMC2635013
      51. Strickler HD, Howard AA, Peters M, Fazzari M, Yu H, Augenbraun M, French AL, Young M, Gange S, Anastos K, Kovacs A. The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women. AIDS. 2008 Feb 19; 22(4):527-31.
        View in: PubMed PMC3507535
      52. Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA. Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75.
        View in: PubMed PMC3184401
      53. Peters MG. Diagnosis and management of hepatitis B virus and HIV coinfection. Top HIV Med. 2007 Nov-Dec; 15(5):163-6.
        View in: PubMed
      54. Wang B, Dolinski BM, Kikuchi N, Leone DR, Peters MG, Weinreb PH, Violette SM, Bissell DM. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology. 2007 Nov; 46(5):1404-12.
        View in: PubMed PMC4144397
      55. Cohen MH, Grey D, Cook JA, Anastos K, Seaberg E, Augenbraun M, Burian P, Peters M, Young M, French A. Awareness of hepatitis C infection among women with and at risk for HIV. J Gen Intern Med. 2007 Dec; 22(12):1689-94.
        View in: PubMed PMC2219830
      56. Peters MG, Di Bisceglie AM, Kowdley KV, Flye NL, Luketic VA, Munoz SJ, Garcia-Tsao G, Boyer TD, Lake JR, Bonacini M, Combes B. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology. 2007 Sep; 46(3):769-75.
        View in: PubMed PMC4167731
      57. Tsui JI, French AL, Seaberg EC, Augenbraun M, Nowicki M, Peters M, Tien PC. Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis. 2007 Sep 15; 45(6):736-40.
        View in: PubMed PMC4142488
      58. Sherman KE, Peters M, Koziel MJ. HIV and liver disease forum: conference proceedings. Hepatology. 2007 Jun; 45(6):1566-77.
        View in: PubMed PMC2786959
      59. Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Bräu N, Hatzakis A, Pol S, Rockstroh J. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS. 2007 May 31; 21(9):1073-89.
        View in: PubMed
      60. Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PA. Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects. Clin Infect Dis. 2007 May 15; 44(10):1375-83.
        View in: PubMed PMC4075655
      61. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med. 2007 Apr 5; 356(14):1445-54.
        View in: PubMed PMC4144044
      62. French AL, Operskalski E, Peters M, Strickler HD, Tien PC, Sharp GB, Glesby MJ, Young M, Augenbraun M, Seaberg E, Kovacs A. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis. 2007 May 15; 195(10):1437-42.
        View in: PubMed PMC3133731
      63. Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT. Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res. 2007 Apr; 27(4):263-9.
        View in: PubMed PMC4066618
      64. Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters MG, Chung RT. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. J Interferon Cytokine Res. 2006 Nov; 26(11):834-8.
        View in: PubMed PMC4113398
      65. Peters MG, Andersen J, Lynch P, Liu T, Alston-Smith B, Brosgart CL, Jacobson JM, Johnson VA, Pollard RB, Rooney JF, Sherman KE, Swindells S, Polsky B. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology. 2006 Nov; 44(5):1110-6.
        View in: PubMed PMC4114764
      66. Buxbaum J, Qian P, Khuu C, Shneider BL, Daikh DI, Gershwin ME, Allen PM, Peters MG. Novel model of antigen-specific induction of bile duct injury. Gastroenterology. 2006 Dec; 131(6):1899-906.
        View in: PubMed PMC4113411
      67. Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant. 2006 Sep-Oct; 20(5):617-23.
        View in: PubMed PMC4050657
      68. Fix OK, Peters MG, Davern TJ. Eosinophilic hepatitis caused by lamotrigine. Clin Gastroenterol Hepatol. 2006 Apr; 4(4):xxvi.
        View in: PubMed PMC4113389
      69. Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS. 2006 Feb 14; 20(3):345-51.
        View in: PubMed PMC4060610
      70. Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, Cooksley WG, Fried MW, Hadziyannis SJ, Liaw YF, Naoumov NV, Schiff ER, Thio CL, Tsai N, Schalm S. Chronic hepatitis B: a critical appraisal of current approaches to therapy. Clin Gastroenterol Hepatol. 2006 Feb; 4(2):233-48.
        View in: PubMed
      71. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2006 Jan 1; 41(1):31-6.
        View in: PubMed PMC4050666
      72. Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers RL, Rosoff L, Garcia-Tsao G, Boyer JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, Barnes DS, Bonacini M, Lindsay KL, Mills AS, Markin RS, Rubin R, West AB, Wheeler DE, Contos MJ, Hofmann AF. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology. 2005 Nov; 42(5):1184-93.
        View in: PubMed
      73. Guy JE, Qian P, Lowell JA, Peters MG. Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver Transpl. 2005 Oct; 11(10):1252-7.
        View in: PubMed PMC4050662
      74. Peters MG. Managing hepatitis B coinfection in HIV-infected patients. Curr HIV/AIDS Rep. 2005 Aug; 2(3):122-6.
        View in: PubMed
      75. Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ. Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS. 2005 May 20; 19(8):767-73.
        View in: PubMed PMC4050654
      76. Sherman KE, Shire NJ, Rouster SD, Peters MG, James Koziel M, Chung RT, Horn PS. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology. 2005 Feb; 128(2):313-27.
        View in: PubMed PMC4036101
      77. Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004 Jul 29; 351(5):451-9.
        View in: PubMed PMC4113392
      78. Quan DJ, Peters MG. Antiviral therapy: nucleotide and nucleoside analogs. Clin Liver Dis. 2004 May; 8(2):371-85.
        View in: PubMed
      79. Combes B, Luketic VA, Peters MG, Zetterman RK, Garcia-Tsao G, Munoz SJ, Lin D, Flye N, Carithers RL. Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am J Gastroenterol. 2004 Feb; 99(2):264-8.
        View in: PubMed PMC3891562
      80. Peters MG, Hann Hw Hw, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df Df, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology. 2004 Jan; 126(1):91-101.
        View in: PubMed
      81. Morgan TR, Brenner D, Everhart J, French SW, Fried MW, Gretch DR, Koziel MJ, McClain CJ, Peters MG, Weinman SA, Lucas DL. Hepatitis C and alcohol: fundamental and translational research directions. Alcohol Clin Exp Res. 2003 Apr; 27(4):726-31.
        View in: PubMed
      82. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, Brown JJ, McFarland EG, Middleton WD, Balfe DM, Ritter JH. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology. 2003 Feb; 226(2):533-42.
        View in: PubMed
      83. Peters MG, Terrault NA. Alcohol use and hepatitis C. Hepatology. 2002 Nov; 36(5 Suppl 1):S220-5.
        View in: PubMed PMC4123319
      84. Peters MG. Animal models of autoimmune liver disease. Immunol Cell Biol. 2002 Feb; 80(1):113-6.
        View in: PubMed
      85. Rubin DC, Zhang H, Qian P, Lorenz RG, Hutton K, Peters MG. Altered enteroendocrine cell expression in T cell receptor alpha chain knock-out mice. Microsc Res Tech. 2000 Oct 15; 51(2):112-20.
        View in: PubMed
      86. Peters MG, Shouval D, Bonham A, Vierling JM, Lok AS. Posttransplantation: future therapies. Semin Liver Dis. 2000; 20 Suppl 1:19-24.
        View in: PubMed
      87. Peters MG, Singer G, Howard T, Jacobsmeyer S, Xiong X, Gibbs CS, Lamy P, Murray A. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation. 1999 Dec 27; 68(12):1912-4.
        View in: PubMed
      88. Combes B, Markin RS, Wheeler DE, Rubin R, West AB, Mills AS, Eigenbrodt EH, Maddrey WC, Munoz SJ, Garcia-Tsao G, Bonner GF, Boyer JL, Luketic VA, Shiffman ML, Peters MG, White HM, Zetterman RK, Carithers RL. The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis. Hepatology. 1999 Sep; 30(3):602-5.
        View in: PubMed PMC3935822
      89. Combes B, Carithers RL, Maddrey WC, Munoz S, Garcia-Tsao G, Bonner GF, Boyer JL, Luketic VA, Shiffman ML, Peters MG, White H, Zetterman RK, Risser R, Rossi SS, Hofmann AF. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology. 1999 Jun; 29(6):1649-54.
        View in: PubMed PMC4004074
      90. Peters MG. Pathogenesis of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangiopathy. Clin Liver Dis. 1998 May; 2(2):235-47, vii-viii.
        View in: PubMed
      91. Teefey SA, Middleton WD, Crowe TM, Peters MG. Doppler sonographic evaluation of the portal vein: effects of intravenous dodecafluoropentane. J Ultrasound Med. 1997 Oct; 16(10):641-5.
        View in: PubMed
      92. Reinhold MI, Lindberg FP, Plas D, Reynolds S, Peters MG, Brown EJ. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Cell Sci. 1995 Nov; 108 ( Pt 11):3419-25.
        View in: PubMed
      93. Okuyama S, Rubin D, Woodley M, Peters MG. Regional expression of murine intestinal immune cells in normal and isografted intestine. Cell Immunol. 1995 Jul; 163(2):198-205.
        View in: PubMed
      94. Lowell JA, Howard TK, White HM, Shenoy S, Huettner PC, Brennan DC, Peters MG. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft. Lancet. 1995 Apr 29; 345(8957):1084-5.
        View in: PubMed
      95. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology. 1995 Jan; 108(1):145-56.
        View in: PubMed
      96. Clatch RJ, Krigman HR, Peters MG, Zutter MM. Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HIV infection and primary myelodysplasia. Br J Haematol. 1994 Dec; 88(4):685-92.
        View in: PubMed
      97. Secrist H, Egan M, Peters MG. Tissue-specific regulation of IL-4 mRNA expression in human tonsil. J Immunol. 1994 Feb 1; 152(3):1120-6.
        View in: PubMed
      98. McCabe RP, Secrist H, Botney M, Egan M, Peters MG. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol. 1993 Jan; 66(1):52-8.
        View in: PubMed
      99. Woodle ES, Perdrizet GA, Brunt EM, So SK, Jendrisak MD, McCullough CS, Vehe KL, White HM, Peters MG, Mohanakumar T, et al. FK506: inhibition of humoral mechanisms of hepatic allograft rejection. Transplantation. 1992 Aug; 54(2):377-81.
        View in: PubMed
      100. Brunt EM, Peters MG, Flye MW, Hanto DW. Day-5 protocol liver allograft biopsies document early rejection episodes and are predictive of recurrent rejection. Surgery. 1992 May; 111(5):511-7.
        View in: PubMed
      101. Woodle ES, Perdrizet GA, Brunt EM, So SK, Jendrisak MD, McCullough CS, Vehe KL, White HM, Peters MG, Marsh JW. FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. Transplant Proc. 1991 Dec; 23(6):2992-3.
        View in: PubMed
      102. Ambrus JL, Haneiwich S, Chesky L, McFarland P, Peters MG, Engler RJ. Abnormal response to a human B cell growth factor in patients with common variable immunodeficiency (CVI). J Allergy Clin Immunol. 1991 Jun; 87(6):1138-49.
        View in: PubMed
      103. Brunt EM, White H, Marsh JW, Holtmann B, Peters MG. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. Hepatology. 1991 Jun; 13(6):1017-21.
        View in: PubMed
      104. Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters MG. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology. 1990 Jan; 11(1):59-64.
        View in: PubMed
      105. Peters MG, Hoffnagle JH, McGarvey C, Fox I, Gregg RE, Jones EA. Primary biliary cirrhosis: management of an unusual case with severe xanthomata by hepatic transplantation. J Clin Gastroenterol. 1989 Dec; 11(6):694-7.
        View in: PubMed
      106. Peters MG, Secrist H, Anders KR, Nash GS, Rich SR, MacDermott RP. Normal human intestinal B lymphocytes. Increased activation compared with peripheral blood. J Clin Invest. 1989 Jun; 83(6):1827-33.
        View in: PubMed PMC303902
      107. Peters MG, Ambrus JL, Fauci AS, Brown EJ. The Bb fragment of complement factor B acts as a B cell growth factor. J Exp Med. 1988 Oct 1; 168(4):1225-35.
        View in: PubMed PMC2189078
      108. Perrillo RP, Regenstein FG, Peters MG, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. Ann Intern Med. 1988 Jul 15; 109(2):95-100.
        View in: PubMed
      109. Hanson RG, Peters MG, Hoofnagle JH. Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis. Hepatology. 1986 Mar-Apr; 6(2):173-9.
        View in: PubMed
      Marion's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP